✦ LIBER ✦
5026 POSTER DISCUSSION Sorafenib (SOR) Plus Chemotherapy (CRx) for Treatment (tx) of Patients (pts) With HER2-negative Locally Advanced (adv) or Metastatic (met) Breast Cancer (BC) and Prior Bevacizumab (BEV): Subgroup Analysis of AC01B07
✍ Scribed by Hudis, C.A.; Hermann, R.C.; Makari-Judson, G.; Isaacs, C.; Beck, J.T.; Kaklamani, V.G.; Rugo, H.S.; Wang, W.; Li, S.; Schwartzberg, L.S.
- Book ID
- 122925633
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 43 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.